Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2687)	2/2/2010 3:03:38 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

ATHX was up 18.48% at its intraday H and is still up 12.77% but has continued to drift down as I am writing.<g> Volume of 1,297,700 is still about half its ADV. bigcharts.marketwatch.com ATHX nnounced today that its CEO, Dr. Gil Van Bokkelen, will present at the 12th Annual BIO CEO & Investor Conference to be held at the Waldorf, Feb8-9. The conference will provide a forum to discuss breakthrough therapeutic developments and issues that affect the biotech industry. The stock is trying to get off from its near term DT after the spike in Dec to the $6.40 level.<g> bigcharts.marketwatch.com ATX has been trimming its loss in the last 3Qs in spite of lower revenues. It has NLTD and the insiders reportedly hold > 35% of the stock. Bernard

To: Jibacoa who wrote (2687)	8/18/2010 9:34:19 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

BSDM will open with a good UG and is up > 50% in pre-market trading.<g> bigcharts.marketwatch.com It announced that the FDA has granted It a 510(k) clearance to market its MTX-180 for ablation of soft tissue.<g> This authorizes the commercial sale of the MTX-180 in the U.S. The MTX-180 utilizes innovative synchronous phased array technology that was developed and patented by BSDM to deliver targeted microwave energy to ablate soft tissue. BSDM has 4Qs of lower revenues, but has been able to trim its losses in the last 2Qs.The EL for the current Yr is around $0.32 vs. $0.52 in 2009. It has NLTD. The insiders reportedly hold cloe to 40% if the shrs. and the short ratio is around 4xits ADV.<g> There is no ACTAY I will keep a TT at the $3 level.<g> bigcharts.marketwatch.com Bernard